Insider Trading History of Vera Juan

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Vera Juan since 2021. This trader's CIK number is 1755495. At the time of last reporting, Vera Juan was the Chief Development Officer of Marker Therapeutics, Inc.. (stock ticker symbol MRKR). Also see all insider trading activities at Marker Therapeutics, Inc..

Note that in the past Vera Juan also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Allovir, Inc. (ALVR) by Vera Juan

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 ALVR 0 $0 127,042 $5,068,636 0 $0

Yearly summary of insider trading at Marker Therapeutics, Inc. (MRKR) by Vera Juan

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 MRKR 571,428 $999,999 0 $0 0 $0


Insider trading activities at 2 companies by Vera Juan:

1. Allovir, Inc. (ALVR)

2. Marker Therapeutics, Inc. (MRKR)

Table 1. Insider trading of Allovir, Inc. (ALVR) by Vera Juan

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-03-01 ALVR Sale 32,854 38.85 1,276,246
2021-03-02 ALVR Sale 14,994 38.23 573,145
2021-03-03 ALVR Sale 15,988 37.95 606,808
2021-02-19 ALVR Sale 13,233 41.79 553,007
2021-02-22 ALVR Sale 14,321 42.59 609,988
2021-02-23 ALVR Sale 8,850 39.63 350,752
2021-02-18 ALVR Sale 8,942 40.47 361,891
2021-02-16 ALVR Sale 10,400 42.16 438,474
2021-02-17 ALVR Sale 7,460 39.99 298,325

Table 2. Insider trading of Marker Therapeutics, Inc. (MRKR) by Vera Juan

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-03-16 MRKR Buy 571,428 1.75 999,999

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Vera Juan (Chief Development Officer of Marker Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.